Calculate your body mass index (BMI)
Pediatric Autism, Smith-Magenis Syndrome, or Legally Blind- 233625
Up to: $800
Male, Female, Non-Smoker
Children and adolescents, ages 3-17, who are diagnosed with Autism Spectrum Disorder (ASD) or Smith-Magenis Syndrome (SMS) and have a nighttime sleep complaint or who are legally blind and have sleep-wake symptoms of Non-24-hour Sleep-Wake Disorder are needed for a clinical trial. The purpose of this is to determine an age-appropriate dose and to assess the safety/tolerability of a single dose of an investigational drug for children and adolescents ages 3-17 years. The investigational drug is currently approved by the United States Food and Drug Administration (FDA) for another indication in adults.